About This Test
CEA is reliable tumour marker for already diagnosed Colo-Rectal carcinoma. Baseline levels measured prior to therapeutic
intervention, and followed later by serial periodical measurements, will predict the outcome of the therapy. It also helps in early
discovery of recurrences, relapses and metastases.
CEA may also be elevated in Carcinomas of Breast, Ovaries, Lungs, Prostrate, Pancreas, Stomach, Liver and thyroid
(Medullary). Nonmalignant conditions showing elevated CEA levels include Ulcerative Colitis, Pancreatitis, Hepatitis, Cirrhosis,
Obstructive Jaundice, Bronchitis and heavy smokers. Therefore, this parameter should never be used as a screening test for
diagnosis of Colo-Rectal Carcinomas, but only as an aid in follow-up studies.
Combined use of CEA with other tumour markers increases sensitivity, specificity and predictability of these parameters
Test Parameters (1)
- CARCINO EMBRYONIC ANTIGEN;CEA,Serum
Home Collection
✓ Available
Reports Available In
1 Day
Preparation / Prerequisite
No Special Requirement
Frequently Asked Questions
These tests measure things like blood sugar, liver function, kidney function, cholesterol and
electrolytes.
electrolytes.
Fasting is not required.
Mon-Sat, sample before 4pm, report same day and sunday reports, next day.
Yes. We use fully automated machines that ensure accurate and consistent results.
Yes - CEA (Carcinoembryonic Antigen) can detect health problems, primarily certain cancers and some non-cancerous conditions, though it is not a stand-alone diagnostic test.
TAT Policy
The Turnaround Time (TAT) depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.
